60 related articles for article (PubMed ID: 660071)
21. Antitumor activities and estrogen receptor interactions of the metabolites of the antiestrogens C1628 and U23,469 in the 7,12-dimethylbenz(a)anthracene-induced rat mammary tumor system.
Rorke EA; Katzenellenbogen BS
Cancer Res; 1981 Apr; 41(4):1257-62. PubMed ID: 6783294
[No Abstract] [Full Text] [Related]
22. [Effect of malignant tumors with various characteristics on the state of the estradiol receptor system in peripheral target organs].
Savinskaia AP; Boguslavskaia EV
Biull Eksp Biol Med; 1984 Jan; 97(1):79-81. PubMed ID: 6546352
[TBL] [Abstract][Full Text] [Related]
23. Polymorphism of estrogen receptors in human breast cancer.
Wittliff JL; Feldhoff PW; Fuchs A; Wiehle RD
Prog Clin Biol Res; 1981; 74():375-96. PubMed ID: 6275406
[No Abstract] [Full Text] [Related]
24. Role of estrogen and prolactin in the growth and receptor levels of N-nitrosomethylurea-induced rat mammary tumors.
Manni A; Rainieri J; Arafah BM; Finegan HM; Pearson OH
Cancer Res; 1982 Sep; 42(9):3492-5. PubMed ID: 6286107
[TBL] [Abstract][Full Text] [Related]
25. Comparison of estrogen receptors in hormone-dependent and hormone-independent Grunder strain mouse mammary tumors.
Moncharmont B; Ramp G; De Goeij CC; Sluyser M
Cancer Res; 1991 Aug; 51(15):3843-8. PubMed ID: 1855202
[TBL] [Abstract][Full Text] [Related]
26. Estrogen receptor binding radiopharmaceuticals: II. Tissue distribution of 17 alpha-methylestradiol in normal and tumor-bearing rats.
Feenstra A; Vaalburg W; Nolten GM; Reiffers S; Talma AG; Wiegman T; van der Molen HD; Woldring MG
J Nucl Med; 1983 Jun; 24(6):522-8. PubMed ID: 6406650
[TBL] [Abstract][Full Text] [Related]
27. The biological significance of estradiol receptor binding to DNA.
Khan S; Feldman M; Hollander VP
Cancer Res; 1980 Apr; 40(4):1050-3. PubMed ID: 7357535
[TBL] [Abstract][Full Text] [Related]
28. Establishment of an in vitro estrogen-dependent mouse mammary tumor model: a new tool to understand estrogen responsiveness and development of tamoxifen resistance in the context of stromal-epithelial interactions.
Pontiggia O; Rodriguez V; Fabris V; Raffo D; Bumaschny V; Fiszman G; de Kier Joffé EB; Simian M
Breast Cancer Res Treat; 2009 Jul; 116(2):247-55. PubMed ID: 18622696
[TBL] [Abstract][Full Text] [Related]
29. Mechanisms by which energy restriction inhibits rat mammary carcinogenesis: in vivo effects of corticosterone on cell cycle machinery in mammary carcinomas.
Zhu Z; Jiang W; Thompson HJ
Carcinogenesis; 2003 Jul; 24(7):1225-31. PubMed ID: 12807724
[TBL] [Abstract][Full Text] [Related]
30. Effects of host hormonal status on binding of activated estrogen receptor to nuclei from R3230AC and 7,12-dimethylbenz[a]anthracene-induced mammary tumors.
Klinge CM; Bambara RA; Zain S; Hilf R
Cancer Res; 1989 Mar; 49(5):1165-70. PubMed ID: 2492902
[TBL] [Abstract][Full Text] [Related]
31. Interactions between prolactin and ovarian secretions during mammary tumorigenesis in the mouse.
Edery M; Goussard J; Vives C; Rudali G; Drosdowsky MA
Biomedicine; 1980 Dec; 33(8):265-7. PubMed ID: 7213925
[TBL] [Abstract][Full Text] [Related]
32. Steroid receptors in mammary glands and tumors of hysterectomised rats.
Seshadri R
Indian J Exp Biol; 1990 Oct; 28(10):920-3. PubMed ID: 2279765
[TBL] [Abstract][Full Text] [Related]
33. Effects of high hoses of estrogen on prolactin-binding activity and growth of carcinogen-induced mammary cancers in rats.
Kledzik GS; Bradley CJ; Marshall S; Campbell GA; Meites J
Cancer Res; 1976 Sep; 36(9 pt.1):3265-8. PubMed ID: 824050
[TBL] [Abstract][Full Text] [Related]
34. Regulation of estrogen-binding capacity by insulin in 7,12-dimethylbenz(a)anthracene-induced mammary tumors in rats.
Gibson SL; Hilf R
Cancer Res; 1980 Jul; 40(7):2343-8. PubMed ID: 6770998
[TBL] [Abstract][Full Text] [Related]
35. Dichotomous effects of tamoxifen on a transplantable rat mammary tumor.
Ip MM; Milholland RJ; Rosen F; Kim U
Cancer Res; 1981 Mar; 41(3):984-8. PubMed ID: 7459886
[TBL] [Abstract][Full Text] [Related]
36. Radiotracers binding to estrogen receptors: I: Tissue distribution of 17 alpha-ethynylestradiol and moxestrol in normal and tumor-bearing rats.
Feenstra A; Nolten GM; Vaalburg W; Reiffers S; Woldring MG
J Nucl Med; 1982 Jul; 23(7):599-605. PubMed ID: 6806452
[TBL] [Abstract][Full Text] [Related]
37. 2-Phenylbenzo[b]furans: relationship between structure, estrogen receptor affinity and cytostatic activity against mammary tumor cells.
Erber S; Ringshandl R; von Angerer E
Anticancer Drug Des; 1991 Nov; 6(5):417-26. PubMed ID: 1764164
[TBL] [Abstract][Full Text] [Related]
38. Growth inhibition of estrogen-sensitive rat mammary tumors. Effect of an alpha-fetoprotein-secreting hepatoma.
Sonnenschein C; Ucci AA; Soto AM
J Natl Cancer Inst; 1980 May; 64(5):1147-52. PubMed ID: 6154169
[TBL] [Abstract][Full Text] [Related]
39. Tamoxifen tolerance and steroid receptors in a tumor model.
Kellen JA; Sutherland DJ
In Vivo; 1988; 2(3-4):299-300. PubMed ID: 2979847
[TBL] [Abstract][Full Text] [Related]
40. Estrogen receptor variants in mouse mammary tumors.
Sluyser M; Dantuma NP; Van Tiggelen C; De Goeij CC
Ann N Y Acad Sci; 1993 Jun; 684():116-8. PubMed ID: 8317824
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
